Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease
- PMID: 16179381
- DOI: 10.1210/me.2005-0287
Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease
Abstract
Androgen-dependent prostate diseases initially require 5alpha-dihydrotestosterone (DHT) for growth. The DHT product 5alpha-androstane-3alpha,17beta-diol (3alpha-diol), is inactive at the androgen receptor (AR), but induces prostate growth, suggesting that an oxidative 3alpha-hydroxysteroid dehydrogenase (HSD) exists. Candidate enzymes that posses 3alpha-HSD activity are type 3 3alpha-HSD (AKR1C2), 11-cis retinol dehydrogenase (RODH 5), L-3-hydroxyacyl coenzyme A dehydrogenase , RODH like 3alpha-HSD (RL-HSD), novel type of human microsomal 3alpha-HSD, and retinol dehydrogenase 4 (RODH 4). In mammalian transfection studies all enzymes except AKR1C2 oxidized 3alpha-diol back to DHT where RODH 5, RODH 4, and RL-HSD were the most efficient. AKR1C2 catalyzed the reduction of DHT to 3alpha-diol, suggesting that its role is to eliminate DHT. Steady-state kinetic parameters indicated that RODH 4 and RL-HSD were high-affinity, low-capacity enzymes whereas RODH 5 was a low-affinity, high-capacity enzyme. AR-dependent reporter gene assays showed that RL-HSD, RODH 5, and RODH 4 shifted the dose-response curve for 3alpha-diol a 100-fold, yielding EC(50) values of 2.5 x 10(-9) M, 1.5 x 10(-9) M, and 1.0 x 10(-9) M, respectively, when compared with the empty vector (EC(50) = 1.9 x 10(-7) M). Real-time RT-PCR indicated that L-3-hydroxyacyl coenzyme A dehydrogenase and RL-HSD were expressed more than 15-fold higher compared with the other candidate oxidative enzymes in human prostate and that RL-HSD and AR were colocalized in primary prostate stromal cells. The data show that the major oxidative 3alpha-HSD in normal human prostate is RL-HSD and may be a new therapeutic target for treating prostate diseases.
Similar articles
-
Pre-receptor regulation of the androgen receptor.Mol Cell Endocrinol. 2008 Jan 16;281(1-2):1-8. doi: 10.1016/j.mce.2007.10.008. Epub 2007 Oct 22. Mol Cell Endocrinol. 2008. PMID: 18060684 Free PMC article. Review.
-
Human type 3 3alpha-hydroxysteroid dehydrogenase (aldo-keto reductase 1C2) and androgen metabolism in prostate cells.Endocrinology. 2003 Jul;144(7):2922-32. doi: 10.1210/en.2002-0032. Endocrinology. 2003. PMID: 12810547
-
Androgen inactivation and steroid-converting enzyme expression in abdominal adipose tissue in men.J Endocrinol. 2006 Dec;191(3):637-49. doi: 10.1677/joe.1.06365. J Endocrinol. 2006. PMID: 17170221
-
Modulation of the androgenic response by recombinant human 11-cis retinol dehydrogenase.J Steroid Biochem Mol Biol. 2001 May;77(2-3):129-33. doi: 10.1016/s0960-0760(01)00038-3. J Steroid Biochem Mol Biol. 2001. PMID: 11377978
-
Identification of the molecular switch that regulates access of 5alpha-DHT to the androgen receptor.Mol Cell Endocrinol. 2007 Feb;265-266:77-82. doi: 10.1016/j.mce.2006.12.007. Epub 2007 Jan 16. Mol Cell Endocrinol. 2007. PMID: 17223255 Free PMC article. Review.
Cited by
-
Outsmarting androgen receptor: creative approaches for targeting aberrant androgen signaling in advanced prostate cancer.Expert Rev Endocrinol Metab. 2011 May;6(3):483-493. doi: 10.1586/eem.11.33. Expert Rev Endocrinol Metab. 2011. PMID: 22389648 Free PMC article.
-
Current advances in intratumoral androgen metabolism in castration-resistant prostate cancer.Curr Opin Endocrinol Diabetes Obes. 2016 Jun;23(3):264-70. doi: 10.1097/MED.0000000000000253. Curr Opin Endocrinol Diabetes Obes. 2016. PMID: 27119752 Free PMC article. Review.
-
Pre-receptor regulation of the androgen receptor.Mol Cell Endocrinol. 2008 Jan 16;281(1-2):1-8. doi: 10.1016/j.mce.2007.10.008. Epub 2007 Oct 22. Mol Cell Endocrinol. 2008. PMID: 18060684 Free PMC article. Review.
-
Molecular mechanisms of enzalutamide resistance in prostate cancer.Cancer Drug Resist. 2019 Jun 19;2(2):189-197. doi: 10.20517/cdr.2019.25. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582713 Free PMC article. Review.
-
Human cytosolic hydroxysteroid dehydrogenases of the aldo-ketoreductase superfamily catalyze reduction of conjugated steroids: implications for phase I and phase II steroid hormone metabolism.J Biol Chem. 2009 Apr 10;284(15):10013-22. doi: 10.1074/jbc.M809465200. Epub 2009 Feb 12. J Biol Chem. 2009. PMID: 19218247 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials